STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Tillgänglig från:

Sanofi-Aventis Australia Pty Ltd

INN (International namn):

prochlorperazine mesilate

Läkemedelsform:

Injection

Sammansättning:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Administreringssätt:

Intramuscular

Enheter i paketet:

10 x 1 mL

Receptbelagda typ:

(S1) This Schedule is intentionally blank

Terapeutiska indikationer:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Produktsammanfattning:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2007-07-16